Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
In vitro modeling of central nervous system myelination and remyelination.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4).
Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases.
Meanings, motivations, and strategies for engaging in physical activity among women with multiple sclerosis.
Multiparametric flow cytometric analysis of whole blood reveals changes in minor lymphocyte subpopulations of multiple sclerosis patients.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial.
Multiple sclerosis and breast cancer.
Epstein-Barr virus: an important vaccine target for cancer prevention.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Neuromyelitis optica spectrum disorder: 2-deoxy-2-[(18)f]fluoro-d-glucose positron emission tomography findings.
Tysabri prescribing information
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
A systematic review of research undertaken in vocational rehabilitation for people with multiple sclerosis.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
Autoimmune myelopathies.
Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients.
Evaluation of an electronic diary for improvement of adherence to interferon beta-1b in patients with multiple sclerosis: design and baseline results of an observational cohort study.

Pages